Department of Biology, University of Texas at San Antonio, San Antonio, TX 78249, USA.
J Immunol. 2011 Mar 1;186(5):2750-6. doi: 10.4049/jimmunol.1000907. Epub 2011 Jan 26.
Ab-mediated blockade of the adhesion molecule VLA-4 has been shown to ameliorate disease in human multiple sclerosis patients and experimental autoimmune encephalomyelitis (EAE) animal models. We wanted to determine whether anti-VLA-4 Ab treatment affected the function and persistence of autoreactive T cells in mice with EAE. Unexpectedly, we observed a high level of mortality in anti-VLA-4 mAb (PS/2)-treated mice with actively induced EAE despite decreased disease severity. Investigation of the underlying mechanism showed that injection of PS/2 mAb in combination with pertussis toxin resulted in anaphylaxis and mortality. Furthermore, the data showed that CD4(+) T cells were required for this effect and suggested a role for IL-1β and TNF-α in the underlying pathology. The results reveal a previously not appreciated deleterious effect of anti-VLA-4 Ab treatment in combination with exposure to pertussis toxin.
Ab 介导的黏附分子 VLA-4 阻断已被证明可以改善人类多发性硬化症患者和实验性自身免疫性脑脊髓炎 (EAE) 动物模型的疾病。我们想确定抗 VLA-4 Ab 治疗是否会影响 EAE 小鼠中自身反应性 T 细胞的功能和持久性。出乎意料的是,我们观察到在主动诱导 EAE 的抗 VLA-4 mAb (PS/2) 治疗小鼠中死亡率很高,尽管疾病严重程度降低。对潜在机制的研究表明,PS/2 mAb 与百日咳毒素联合注射会导致过敏反应和死亡。此外,数据表明 CD4(+) T 细胞是产生这种效应所必需的,并且表明 IL-1β 和 TNF-α 在潜在病理中起作用。结果揭示了先前未被注意到的抗 VLA-4 Ab 治疗与百日咳毒素暴露联合使用的有害影响。